Ameritas Investment Partners’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
Other funds holding TMCI
AC
GS
VCM
CBU
Ameritas Investment Partners's TMCI Position: Q1 2026 in Review
Ameritas Investment Partners held its Treace Medical Concepts (TMCI) position steady in Q1 2026 at 4,493 shares worth $6.02K. The position accounts for ﹤0.01% of the portfolio, ranked #2961.
Ameritas Investment Partners first reported a position in TMCI in Q2 2021 and has held it in 20 quarters since. The position peaked at $95.5K in Q2 2023. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.
- Ameritas Investment Partners held 4,493 shares of Treace Medical Concepts worth $6.02K as of Q1 2026.
- Ameritas Investment Partners left its Treace Medical Concepts share count unchanged in Q1 2026.
- Treace Medical Concepts made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2961 holding.
- Ameritas Investment Partners first reported a position in Treace Medical Concepts in Q2 2021 and has held it in 20 quarters since.
- Ameritas Investment Partners's Treace Medical Concepts position peaked at $95.5K in Q2 2023.
- 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.
Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.